Vanda Pharmaceuticals
VNDA
$4.62
Share price
3.12%
Change (1 day)
-24.76%
Change (1 year)
Categories
Earnings for Vanda Pharmaceuticals (VNDA)
Earnings in 2023 (TTM): -$13.96 M
According to Vanda Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$13.96 M. In 2022 the company made an earning of $6.32 M a decrease over its 2021 earnings that were of $42.16 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Vanda Pharmaceuticals from 2005 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$13.96 M | -320.45% |
| 2022 | $6.32 M | -84.99% |
| 2021 | $42.16 M | 54.8% |
| 2020 | $27.23 M | 19.42% |
| 2019 | $22.81 M | 4.93% |
| 2018 | $21.73 M | -228.6% |
| 2017 | -$16.91 M | -8.98% |
| 2016 | -$18.58 M | -53.79% |
| 2015 | -$40.19 M | -30.18% |
| 2014 | -$57.56 M | 173.08% |
| 2013 | -$21.08 M | -25.33% |
| 2012 | -$28.23 M | 163.61% |
| 2011 | -$10.71 M | -221.15% |
| 2010 | $8.83 M | -124.53% |
| 2009 | -$36.04 M | -29.44% |
| 2008 | -$51.07 M | -36.2% |
| 2007 | -$80.04 M | 21.81% |
| 2006 | -$65.71 M | 170.55% |
| 2005 | -$24.29 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -121,745.64% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -70,534.35% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | -23,516.00% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -47,079.64% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -21,853.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 41,800.80% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | -$5.57 M | -60.08% | 🇺🇸 USA |